Skip to main content
Indian stocks: Visit www.stage2stocks.com →

Conexeu Sciences Inc.

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. More about the company

$3.30
-2.25% today
$93.1M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Not enough history to read yet

Setup score

—

Momentum

Steady

Edge

—

Is CNXU early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2026-05-21 → 2026-10-22
S? 22w
2026-05-212026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 22w current
Total tracked: 22 weeks across 1 stage run.

CNXU among Biotechnology585th of 591 by relative strength

All 591 →
Stocks in Biotechnology ranked by relative strength, with stage and one-month change
#StockStageRS1M
1GTBPStage 2 · wk 799−22.3%
2IOVAStage 2 · wk 1899+38.8%
3SLSStage 3 · wk 499−1.5%
4MRNAStage 2 · wk 1799+11.3%
5TWSTStage 2 · wk 3999−14.5%
6KODStage 2 · wk 499+172.1%
7ERASStage 3 · wk 599+0.7%
8CLYMStage 3 · wk 399−15.8%
…585CNXU——−21.6%
vs 52W High
—
Stock is basing below old highs. A volume-backed breakout to new highs would be the Stage 2 signal to watch.
Stage Maturity
Week 22
1w13w26w
Week 22, proven structure
How long this stock has been basing. Longer bases can produce stronger breakouts, but the breakout itself is the signal.
vs 200 DMA
—
—
Stock is testing its 200 DMA as part of the base. Reclaiming and holding above it is a key Stage 2 prerequisite.
Rel Volume
0.70x
vs 50-day avg
Volume in Stage 1 basing is typically quiet. A surge in volume on an upside breakout is the signal to watch.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-21.6%
3M
-61.5%
6M
—
YTD
—
1Y
—
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S—
Wk 22 · Vol 0.70x
2026-10-21S—
Wk 22 · Vol 1.42x
2026-10-20S—
Wk 21 · Vol 2.13x
2026-10-19S—
Wk 21 · Vol 1.40x
2026-10-16S—
Wk 21 · Vol 2.50x
2026-10-15S—
Wk 21 · Vol 2.33x
2026-10-14S—
Wk 21 · Vol 4.84x
2026-10-13S—
Wk 20 · Vol 1.21x
2026-10-12S—
Wk 20 · Vol 1.58x
2026-10-09S—
Wk 20 · Vol 1.90x
2026-10-08S—
Wk 20 · Vol 1.09x
2026-10-07S—
Wk 20 · Vol 1.09x
Moving averages & range
50 DMA
$5.17
200 DMA
—
52W High
—
52W Low
—
5D Low
$2.99
Resistance levels (recent highs)
20d High
$3.95
60d High
$9.99
120d High
—
250d High
—
Next resistance
+19.7%
to 20d High
ROE
-332.9%
Profit margin 0.0%
Dividend Yield
0.00%
P/B 15.4

Conexeu Sciences: quick answers

Which sector and industry is Conexeu Sciences in?

Conexeu Sciences is in the Biotechnology industry, part of the Health Care sector.

About this companyHealth Care· Biotechnology

Conexeu Sciences Inc. develops collagen-based regenerative tissue scaffold products for applications in medical aesthetics and tissue repair. The company provides patented collagen-based scaffold products, including a collagen extracellular matrix (ECM) scaffold platform for use in medical aesthetics, wound care, tissue repair, facial rejuvenation, and large-volume body contouring such as face, breast, and butt volume restoration. Its CXU collagen gel is an investigational product targeting therapeutic and aesthetic indications, supporting tissue regeneration and aiming to minimize inflammation or fibrosis. The company's solutions are supported by preclinical and peer-reviewed data and are positioned as alternatives to conventional fillers or implants, with products currently investigational and pending regulatory clearance for certain applications. The company serves clients in the beauty, aesthetics, regenerative medicine, and medical sectors, including clinicians and professionals involved in facial rejuvenation, body contouring, wound care, and tissue repair. The company was founded in 2022 and is based in Reno, Nevada.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.